Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Hexylresorcinol may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for This medicine contains an active ingredient for use in throat medications. It is used for the symptomatic relief of sore throat and its associated pain. The active ingredient has a mild antiseptic effect to kill the bacteria associated with mouth and throat infections and also acts as a local anaesthetic to numb the pain associated with a sore throat. Sucking the lozenge slowly in the mouth helps to lubricate and soothe the discomfort of the painful area in the throat, and also releases the active ingredient to help relieve the soreness and discomfort of mouth and throat infections.
e this medicine This medicine is recommended for adults, children (over 6 years old) and the elderly. Children under 6 years old should not use this medicine . Do not take this medicine if you:
this medicine Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. Adults, Children (over 6 years old) and the elderly – One lozenge to be dissolved slowly in the mouth every 2 – 3 hours up to a maximum of 12 lozenges in 24 hours Remove one lozenge from the foil blister packaging. Replace the foil blister back into the cardboard carton. Place lozenge into the mouth allowing it to dissolve slowly. Dissolve one lozenge slowly in the mouth every 2 – 3 hours. It is not recommended that children under 6 years use this medicine. Remember that young children can choke on lozenges. If symptoms persist for more than 3 days or if anything unusual happens please consult your doctor. If you take more of this medicine than you should You may experience stomach discomfort Do not take any more of this medicine and consult your doctor or pharmacist. If you forget to take this medicine Do not take a double dose to make up for a forgotten lozenge. Continue to use this medicine normally. If you have any further questions on the use of this medicine ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If you experience any hypersensitivity to this medicine i.e. itching, difficulty in breathing, swelling of the face, neck, tongue or throat and rash (severe allergic reactions) stop taking this medicine and consult your doctor or pharmacist. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
this medicine Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month and the year. Do not store above 25°C. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
What this medicine contains The active substance is: Hexylresorcinol 2.4mg The other ingredients are: Liquid sucrose, Liquid glucose (containing wheat starch (containing gluten) and sulphites – sulphur dioxide (E220)), Blackcurrant flavour (containing Propylene glycol, d-Limonene and Linalool), Levomenthol, Carmoisine Edicol (E122), Patent Blue V (E131). What this medicine looks like and contents of the pack A round purple lozenge. In pack sizes of 2, 4, 6, 8, 12, 16, 24, 32, 36 and 48 lozenges. Not all pack sizes may be marketed. Marketing Authorisation Holder: Reckitt Benckiser Healthcare (UK) Limited, Slough, SL1 3UH Manufacturers: Reckitt Benckiser Healthcare International Limited, Thane road, Nottingham, NG90 2DB, UK. RB NL Brands B.V., WTC Schiphol Airport, Schiphol Boulevard 207, 1118 BH Schiphol, NL. Licence Number: PL 00063/0392 Date of preparation: December 2021
0000000
Package Leaflet: Information for the user STREPSILS Extra Triple Action Blackcurrant Lozenges Hexylresorcinol
CUSTOMER INFO: Minimum Point Size = 9.00pt
1.3.1 Package Leaflet – Clean – Triple Action Strepsils Extra Blackcurrant Hexylresorcinol HBAV9 eCTD
Page 1
TR2252226
D
The active substance in Strepsils Extra Triple Action Blackcurrant Lozenges is hexylresorcinol.
Medicines with the same active substance, strength and form include: Strepsils Extra Triple Action Cherry Lozenges. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Strepsils Extra Triple Action Blackcurrant Lozenges, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
As an antiseptic and local anaesthetic for the relief of sore throat and its associated pain.
For oral administration.
Adults, the elderly and children 6 years and over: One lozenge dissolved slowly in the mouth every three hours or as required.
Do not take more than 12 lozenges in 24 hours.
Not to be given to children under 6 years.
Hypersensitivity to any of the ingredients.
The label will convey:
Keep out of the reach and sight of children.
If symptoms persist consult your doctor.
Not to be given to children under 6 years.
Important information about some of the ingredients of this medicine
• This medicine contains only very low levels of gluten (from wheat starch). It is regarded as 'gluten-free' and is very unlikely to cause problems if you have coeliac disease.
One lozenge contains no more than 22.42 micrograms of gluten.
If you have wheat allergy (different from coeliac disease) you should not take this medicine.
• This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially 'sodium-free'.
• This medicine contains fragrance with d-Limonene and Linalool.
d-Limonene and Linalool may cause allergic reactions.
• This medicine contains carmoisine (E122) which may cause allergic reactions
• This medicine contains Sulphites – Sulphur Dioxide (E220) – present in liquid glucose which may rarely cause severe hypersensitivity reactions and bronchospasm.
• Patients with rare glucose-galactose malabsorption should not take this medicine
• Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
None known.
There is lack of evidence of safety of the product in human pregnancy and in animals, but hexylresorcinol has been used widely in lozenges for many years without apparent ill consequence. However, as with all medicines, caution should be exercised during pregnancy and lactation.
None known.
System Organ Class
Frequency
Adverse Events
Immune System Disorders
Not known
Hypersensitivity1
1 Hypersensitivity reactions may include rash, urticaria and angioedema, which may include swelling of the face, neck, throat or tongue that could affect breathing.
Reporting of Suspected Adverse Reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Hexylresorcinol overdosage may cause minor gastrointestinal irritation. Treatment would be withdrawal of the product and symptomatic measures as appropriate.
Ask anything about Strepsils Extra Triple Action Blackcurrant Lozenges. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.